English
Segment disclosures
Company overviewScienture Holdings, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
14 dimension combinations 111 retained observations 25 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Community Specialty Pharmacy LLC
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=MEDS:CommunitySpecialtyPharmacyLLCMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-06-30 | 637068 | USD | 20230818 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 311257 | USD | 20230515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1175474 | USD | 20230418 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 905083 | USD | 20221128 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 563943 | USD | 20230818 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 268407 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1652841 | USD | 20230418 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 1287296 | USD | 20221128 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 832243 | USD | 20220725 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 397896 | USD | 20220509 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1653924 | USD | 20221128 | Open filing evidence |
Integra
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=MEDS:IntegraMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 18699 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 18699 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1363830 | USD | 20240422 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 366526 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 842882 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 476356 | USD | 20240626 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 4754067 | USD | 20240422 | Open filing evidence |
Integra Pharma LLC
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=MEDS:IntegraPharmaLLCMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-06-30 | 842882 | USD | 20230818 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 476356 | USD | 20230515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 4754067 | USD | 20230418 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 3949772 | USD | 20221128 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 3241965 | USD | 20230818 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1567530 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 3250561 | USD | 20230418 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 2511270 | USD | 20221128 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 1715466 | USD | 20220725 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 1402586 | USD | 20220509 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 9877067 | USD | 20221128 | Open filing evidence |
IPS
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=MEDS:IPSMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-09-30 | 1237731 | USD | 20240116 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 3949772 | USD | 20240116 | Open filing evidence |
Superlatus
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=MEDS:SuperlatusMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 487021 | USD | 20240422 | Open filing evidence |
Trxade Inc
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=MEDS:TrxadeIncMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 6402159 | USD | 20240422 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 4663756 | USD | 20240116 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 3000020 | USD | 20230818 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1443177 | USD | 20230515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 5435814 | USD | 20240422 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 4001670 | USD | 20240116 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 2664237 | USD | 20230818 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1381963 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 4924015 | USD | 20230418 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 3653269 | USD | 20221128 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 2387360 | USD | 20220725 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 1236650 | USD | 20220509 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 5546746 | USD | 20221128 | Open filing evidence |
Unallocated Segments
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=MEDS:UnallocatedSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 16960 | USD | 20240626 | Open filing evidence |
Integra
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=SCNX:IntegraMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 10258 | USD | 20250512 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 136643 | USD | 20250326 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 64861 | USD | 20241106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 83560 | USD | 20241106 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1363830 | USD | 20250326 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 392286 | USD | 20241106 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1235168 | USD | 20241106 | Open filing evidence |
Community Specialty Pharmacy LLC
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=TRXD:CommunitySpecialtyPharmacyLLCMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-09-30 | 1287296 | USD | 20211025 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 832243 | USD | 20210726 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 397896 | USD | 20210426 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1653924 | USD | 20210329 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 1287197 | USD | 20211025 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 870637 | USD | 20210726 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 432929 | USD | 20210426 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1888086 | USD | 20210329 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 1412449 | USD | 20201026 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 892357 | USD | 20200727 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 442423 | USD | 20200504 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 395418 | USD | 20200330 | Open filing evidence |
Integra Pharma LLC
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=TRXD:IntegraPharmaLLCMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-09-30 | 2511270 | USD | 20211025 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 1715466 | USD | 20210726 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 1402586 | USD | 20210426 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 9877067 | USD | 20210329 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 9548512 | USD | 20211025 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 5003523 | USD | 20210726 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 245016 | USD | 20210426 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1020438 | USD | 20210329 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 992862 | USD | 20201026 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 353910 | USD | 20200727 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 26288 | USD | 20200504 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 28538 | USD | 20200330 | Open filing evidence |
Other
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=TRXD:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-06-30 | 353910 | USD | 20191015 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 26288 | USD | 20190513 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 28538 | USD | 20191217 | Open filing evidence |
Other Segments
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=TRXD:OtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-09-30 | 23898 | USD | 20201026 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 7260 | USD | 20200727 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 5468 | USD | 20200504 | Open filing evidence |
Trxade Inc
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=TRXD:TrxadeIncMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-09-30 | 3653269 | USD | 20211025 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 2387360 | USD | 20210726 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 1236650 | USD | 20210426 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 5546746 | USD | 20210329 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 4268619 | USD | 20211025 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 2914537 | USD | 20210726 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 1519907 | USD | 20210426 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 4527740 | USD | 20210329 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 3335050 | USD | 20201026 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 2182668 | USD | 20200727 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 1043810 | USD | 20200504 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 3407822 | USD | 20200330 | Open filing evidence |
All Other Segments
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 19204 | USD | 20240422 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 18299 | USD | 20240116 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 18856 | USD | 20230818 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 16960 | USD | 20230515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 60287 Restated | USD | 20240422 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 42363 Restated | USD | 20240116 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 48856 | USD | 20230818 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 22372 | USD | 20230515 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 62016 | USD | 20230418 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 49700 | USD | 20221128 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 16420 | USD | 20220725 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 16103 | USD | 20220509 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 44783 | USD | 20221128 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 23898 | USD | 20211025 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 7260 | USD | 20210726 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 5468 | USD | 20210426 | Open filing evidence |